PL410369A1 - New peptide derivatives, method for obtaining them, pharmaceutical composition, disinfecting composition and their application and a set - Google Patents

New peptide derivatives, method for obtaining them, pharmaceutical composition, disinfecting composition and their application and a set

Info

Publication number
PL410369A1
PL410369A1 PL410369A PL41036914A PL410369A1 PL 410369 A1 PL410369 A1 PL 410369A1 PL 410369 A PL410369 A PL 410369A PL 41036914 A PL41036914 A PL 41036914A PL 410369 A1 PL410369 A1 PL 410369A1
Authority
PL
Poland
Prior art keywords
new peptide
peptide derivatives
obtaining
application
composition
Prior art date
Application number
PL410369A
Other languages
Polish (pl)
Other versions
PL226054B1 (en
Inventor
Anna Karafova
Wojciech Kamysz
Original Assignee
Gdański Uniwersytet Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gdański Uniwersytet Medyczny filed Critical Gdański Uniwersytet Medyczny
Priority to PL410369A priority Critical patent/PL226054B1/en
Publication of PL410369A1 publication Critical patent/PL410369A1/en
Publication of PL226054B1 publication Critical patent/PL226054B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Przedmiotem wynalazku są nowe pochodne peptydowe o wzorze ogólnym 1: DOCA - PABA - KTFAR - NH2; DOCA - RRPK TFAKTFA - NH2. Ujawniono również sposób otrzymywania nowych pochodnych peptydowych, kompozycję farmaceutyczną oraz dezynfekującą zawierającą jako substancję czynną nowe pochodne peptydowe. Ponadto przedmiotem wynalazku jest zastosowanie nowych związków peptydowych do wytwarzania produktu leczniczego do leczenia chorób wywołanych aktywnością bakteryjną i/lub grzybiczą.The present invention relates to new peptide derivatives of general formula 1: DOCA - PABA - KTFAR - NH2; DOCA - RRPK TFAKTFA - NH2. Also disclosed is the method of obtaining new peptide derivatives, a pharmaceutical and disinfecting composition containing the new peptide derivatives as active substance. The invention furthermore relates to the use of new peptide compounds in the manufacture of a medicinal product for the treatment of diseases caused by bacterial and / or fungal activity.

PL410369A 2014-12-04 2014-12-04 New peptide derivatives, method for obtaining them, pharmaceutical composition, disinfecting composition and their application and a set PL226054B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL410369A PL226054B1 (en) 2014-12-04 2014-12-04 New peptide derivatives, method for obtaining them, pharmaceutical composition, disinfecting composition and their application and a set

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL410369A PL226054B1 (en) 2014-12-04 2014-12-04 New peptide derivatives, method for obtaining them, pharmaceutical composition, disinfecting composition and their application and a set

Publications (2)

Publication Number Publication Date
PL410369A1 true PL410369A1 (en) 2016-06-06
PL226054B1 PL226054B1 (en) 2017-06-30

Family

ID=56086956

Family Applications (1)

Application Number Title Priority Date Filing Date
PL410369A PL226054B1 (en) 2014-12-04 2014-12-04 New peptide derivatives, method for obtaining them, pharmaceutical composition, disinfecting composition and their application and a set

Country Status (1)

Country Link
PL (1) PL226054B1 (en)

Also Published As

Publication number Publication date
PL226054B1 (en) 2017-06-30

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2019005379A (en) Pyrazolo-heteroaryl derivative, preparation method and medical use thereof.
EA201691803A1 (en) HUMAN PLASMA KALLIKREIN INHIBITORS
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
MX368504B (en) Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof.
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
MX2015008957A (en) Fluoro-[1,3]oxazines as bace1 inhibitors.
BR112015023948A2 (en) compound of formula (i), pharmaceutical composition, method for treating and / or preventing a proliferative disease and for inhibiting or differentiating growth of a cancer stem cell
DOP2019000193A (en) NEW HETEROCYCLIC COMPOUND, ITS PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
EA201591371A1 (en) Pyridine derivatives as easily degraded inhibitors ROCK
MX2020011818A (en) Pyridinecarboxamide derivatives, preparation method therefor and pharmaceutical uses thereof.
PH12015502365A1 (en) Bace1 inhibitors
CY1122689T1 (en) PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
PH12018501362A1 (en) Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
EA201690386A1 (en) COMPOUNDS AND COMPOSITIONS AS MEK INHIBITORS
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
EA201790949A1 (en) SUBSTITUTED 2,4-DIAMINOCHINOLINES AS NEW ANTI-CANCER FACILITIES
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
SA521422152B1 (en) Heteroaromatic compounds as vanin inhibitors
BR112017004580A2 (en) compound, pharmaceutical composition, combination product, use of a pharmaceutically acceptable compound or salt, and method of treatment.
AU2015280874A1 (en) Novel heterocyclic compound
MX2021006490A (en) Heteroaromatic compounds as vanin inhibitors.
MY197518A (en) Preventive and/or therapeutic agent of immune disease
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
PL410369A1 (en) New peptide derivatives, method for obtaining them, pharmaceutical composition, disinfecting composition and their application and a set